Clinical and epidemiological data indicate that the oral contraceptives are thrombogenic.
The important papers concerning the effects of oral contraceptives on hemostatic …

Oral contraceptives have been linked to an increased incidence of thrombovascular
disease. This may be mediated by their effects on the haemostatic system. An increase in …

Three large British studies on the vascular effects of oral contraceptives have established
that the risk of thrornboembolic episodes, both venous and arterial, rises with increasing …

Based on epidemiologic data, women who take oral contraceptives seem to have an
increased risk of developing thromboembolic disease. In order to explain this association …

In Europe and North America, estrogen/progestogen oral contraception has been
associated with an increase in venous thromboembolism, myocardial infarction, and stroke …

Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives are of
interest to study because there may be a connection between the use of oral contraceptives …

The use of oral contraceptives is associated with altered plasma concentrations of many
components of the coagulation and fibrinolysis system, increased plasma levels of markers …

Hundreds of millions of women worldwide use either oral contraceptives or postmenopausal
hormone replacement. The use of oral contraceptives leads to an increased risk of venous …

In this issue of Cardiovascular Research Nagai and second generation oral contraceptives
and post-menopausal colleagues present interesting data on the effect of post- estrogen …

Oral contraceptives (OCs) raise the plasma levels of some clotting factors, especially factor
VII. Until recently, however, there has been no evidence for a relationship between high …